U.S, February 10, 2020 (GREENMARKETREPORT) Cannabis, to some, is seen as a risky market. Bankers, the government, and society, in general, all have their own hesitations with the industry. This rings true for investors, too. FINANCIAL-investors-tell-cannabis-companies-prove-it-before-opening-wallet
Some financial experts are adamant about the importance...
U.S, January 20, 2020 (ANALYTICALCANNABIS) Marijuana use is rising among US patients with cardiovascular disease, researchers have warned.
Published in the Journal of the American College of Cardiology today, a new review article has estimated that 2 million US marijuana users were living with cardiovascular...
CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...
UNITED STATES, June 24, 2019 (Web MD)- Cannabidiol, or CBD, already being researched and used for anxiety, insomnia, epilepsy and pain, may be the next superbug fighter for resistant infections, a new study suggests.The researchers tested CBD against a wide variety of bacteria, ''including bacteria that have become resistant to the most commonly...
U.S, December 21, 2019 (INDEPENDENT) Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed.
Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6...
U.S, January 20, 2020 (GREENENTREPRENEUR) CBD and THC are the most visible cannabinoids in the wellness and skincare industries today, but with more than 100 known cannabinoids, others are muscling in.
Fueled by growing consumer interest, technological innovation and an ever-expanding body of scientific...